Abstract 9256: Integrating High-Sensitivity C-Reactive Protein Into Risk Equations for Individuals with Established Atherosclerotic Cardiovascular Disease
Background: Cardiovascular (CV) inflammation, measured by high-sensitivity C-reactive protein (hsCRP), is associated with higher residual CV risk in patients with atherosclerotic CV disease (ASCVD). HsCRP is included in the secondary CV risk prediction tool Secondary Manifestations of ARTerial disease 2 (SMART2) in...